freya tirzepatide #freyameds #tirzepatidejourney Week 2 on tirzepatide with

Theyre very knowledgeable, patient and thorough

This context-specific regulation of macrophage activation likely underlies the divergent inflammatory outcomes observed in the liver and adipose tissue during pharmacological weight loss

Because lean mass is often used as a proxy for muscle mass, the findings have fueled concerns that people taking GLP-1 medications may be sacrificing strength and long-term physical function in pursuit of weight loss

The addition of an sMRA to background ACEI or angiotensin receptor blocker (ARB) therapy increased the risk of hyperkalemia by fourfold to 13-fold, reinforcing the importance of vigilant monitoring in these patients [55]

Pyrshev KA, Klymchenko AS, Cscs G, Demchenko AP

Private label pumps up protein & fiber, but avoids GLP-1 positioning